Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Jan 1;81(1):136-151.
doi: 10.1097/HEP.0000000000000862. Epub 2024 Mar 27.

A randomized multicenter trial of a chronic disease management intervention for decompensated cirrhosis. The A ustra l ian L iver F a i lur e (ALFIE) trial

Alan J Wigg  1   2 , Sumudu Narayana  1 , Richard J Woodman  2 , Leon A Adams  3   4 , Rachel Wundke  1 , Mohamed A Chinnaratha  5 , Bin Chen  5 , Gary Jeffrey  3   4 , Joan-Lee Plummer  4 , Vanessa Sheehan  4 , Edmund Tse  6 , Joanne Morgan  6 , Dep Huynh  7 , Margery Milner  7 , Jeffrey Stewart  7 , Golo Ahlensteil  8   9 , Asma Baig  8 , Billingsley Kaambwa  2 , Kate Muller  1   2 , Jeyamani Ramachandran  1   2
Affiliations
Randomized Controlled Trial

A randomized multicenter trial of a chronic disease management intervention for decompensated cirrhosis. The A ustra l ian L iver F a i lur e (ALFIE) trial

Alan J Wigg et al. Hepatology. .

Abstract

Background and aims: Improving the care of decompensated cirrhosis is a significant clinical challenge. The primary aim of this trial was to assess the efficacy of a chronic disease management (CDM) model to reduce liver-related emergency admissions (LREA). The secondary aims were to assess model effects on quality-of-care and patient-reported outcomes.

Approach and results: The study design was a 2-year, multicenter, randomized controlled study with 1:1 allocation of a CDM model versus usual care. The study setting involved both tertiary and community care. Participants were randomly allocated following a decompensated cirrhosis admission. The intervention was a multifaceted CDM model coordinated by a liver nurse. A total of 147 participants (intervention=75, control=71) were recruited with a median Model for End-Stage Liver Disease score of 19. For the primary outcome, there was no difference in the overall LREA rate for the intervention group versus the control group (incident rate ratio 0.89; 95% CI: 0.53-1.50, p =0.666) or in actuarial survival (HR=1.14; 95% CI: 0.66-1.96, p =0.646). However, there was a reduced risk of LREA due to encephalopathy in the intervention versus control group (HR=1.87; 95% CI: 1.18-2.96, p =0.007). Significant improvement in quality-of-care measures was seen for the performance of bone density ( p <0.001), vitamin D testing ( p <0.001), and HCC surveillance adherence ( p =0.050). For assessable participants (44/74 intervention, 32/71 controls) significant improvements in patient-reported outcomes at 3 months were seen in self-management ability and quality of life as assessed by visual analog scale ( p =0.044).

Conclusions: This CDM intervention did not reduce overall LREA events and may not be effective in decompensated cirrhosis for this end point.

PubMed Disclaimer

Comment in

References

    1. Bajaj JS, Reddy KR, Tandon P, Wong F, Kamath PS, Garcia‐Tsao G, et al. The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis. Hepatology. 2016;64:200–8.
    1. Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol. 2012;107:247–52.
    1. Volk ML, Mellinger J, Bansal MB, Gellad ZF, McClellan M, Kanwal F. A roadmap for value-based payment models among patients with cirrhosis. Hepatology. 2019;69:1300–5.
    1. Kim D, Li AA, Perumpail BJ, Gadiparthi C, Kim W, Cholankeril G, et al. Changing trends in etiology-based and ethnicity-based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States. Hepatology. 2019;69:1064–74.
    1. Powell EE, Skoien R, Rahman T, Clark PJ, O'Beirne J, Hartel G, et al. Increasing hospitalization rates for cirrhosis: overrepresentation of disadvantaged Australians. EClinicalMedicine. 2019;11:44–53.

Publication types